Literature DB >> 12048226

Lyme disease incidence in Wisconsin: a comparison of state-reported rates and rates from a population-based cohort.

Allison L Naleway1, Edward A Belongia, James J Kazmierczak, Robert T Greenlee, Jeffrey P Davis.   

Abstract

Few studies have assessed the accuracy and completeness of Lyme disease surveillance systems. Lyme disease cases were identified through review of medical records for residents of the Marshfield Epidemiologic Study Area (MESA), a population-based cohort of nearly 80,000 in north-central Wisconsin for which comprehensive medical care data are available through the Marshfield Clinic. These cases were compared with cases reported to the Wisconsin Division of Public Health to estimate the completeness of reporting. Annual incidence rates were calculated for MESA using the cases identified from chart review. Division of Public Health data were used to calculate statewide reported incidence rates, as well as rates for an eight-county region that surrounds and includes the MESA region. Of Lyme disease cases meeting the national case definition identified in MESA, 34% were reported to the state. The average incidence of Lyme disease (1992-1998) was 19.1 per 100,000 per year in MESA, 17.0 in the surrounding eight-county region, and 9.0 statewide. Trends in reported incidence across time, gender, and age in the surrounding eight-county region were generally comparable with those observed in MESA. These findings suggest that the passive surveillance system monitored trends in Lyme disease incidence reasonably well despite underreporting of cases.

Entities:  

Mesh:

Year:  2002        PMID: 12048226     DOI: 10.1093/aje/155.12.1120

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

Review 1.  Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA).

Authors:  Robert T Greenlee
Journal:  Clin Med Res       Date:  2003-10

Review 2.  Lyme disease ecology in a changing world: consensus, uncertainty and critical gaps for improving control.

Authors:  A Marm Kilpatrick; Andrew D M Dobson; Taal Levi; Daniel J Salkeld; Andrea Swei; Howard S Ginsberg; Anne Kjemtrup; Kerry A Padgett; Per M Jensen; Durland Fish; Nick H Ogden; Maria A Diuk-Wasser
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-06-05       Impact factor: 6.237

Review 3.  Spatial dynamics of lyme disease: a review.

Authors:  Mary E Killilea; Andrea Swei; Robert S Lane; Cheryl J Briggs; Richard S Ostfeld
Journal:  Ecohealth       Date:  2008-06-05       Impact factor: 3.184

Review 4.  Lyme neuroborreliosis-epidemiology, diagnosis and management.

Authors:  Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

5.  Lyme disease testing by large commercial laboratories in the United States.

Authors:  Alison F Hinckley; Neeta P Connally; James I Meek; Barbara J Johnson; Melissa M Kemperman; Katherine A Feldman; Jennifer L White; Paul S Mead
Journal:  Clin Infect Dis       Date:  2014-05-30       Impact factor: 9.079

6.  A scoping review of Lyme disease research relevant to public health.

Authors:  J D Greig; I Young; S Harding; M Mascarenhas; L A Waddell
Journal:  Can Commun Dis Rep       Date:  2018-10-04

7.  Antibody testing and Lyme disease risk.

Authors:  Elizabeth G Stone; Eleanor H Lacombe; Peter W Rand
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

8.  Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005-2010.

Authors:  Christina A Nelson; Shubhayu Saha; Kiersten J Kugeler; Mark J Delorey; Manjunath B Shankar; Alison F Hinckley; Paul S Mead
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

9.  Environmental risk from Lyme disease in central and eastern Canada: a summary of recent surveillance information.

Authors:  N H Ogden; J K Koffi; Y Pelcat; L R Lindsay
Journal:  Can Commun Dis Rep       Date:  2014-03-06

10.  Surveillance for Lyme disease in Canada, 2009 to 2012.

Authors:  N H Ogden; J K Koffi; L R Lindsay; S Fleming; D C Mombourquette; C Sanford; J Badcock; R R Gad; N Jain-Sheehan; S Moore; C Russell; L Hobbs; R Baydack; S Graham-Derham; L Lachance; K Simmonds; A N Scott
Journal:  Can Commun Dis Rep       Date:  2015-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.